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Introduction: Endothelial progenitor cells (EPCs) display a unique ability to promote
angiogenesis and restore endothelial function in injured blood vessels. NADPH oxidase 4
(NOX4)-derived hydrogen peroxide (H2O2) serves as a signaling molecule and promotes
endothelial cell proliferation and migration as well as protecting against cell death.
However, the role of NOX4 in EPC function is not completely understood.
Methods: EPCs were isolated from human saphenous vein and mammary artery
discarded during bypass surgery. NOX4 gene and protein expression in EPCs were
measured by real time-PCR and Western blot analysis respectively. NOX4 gene
expression was inhibited using an adenoviral vector expressing human NOX4 shRNA
(Ad-NOX4i). H2O2 production was measured by Amplex red assay. EPC migration was
evaluated using a transwell migration assay. EPC proliferation and viability weremeasured
using trypan blue counts.
Results: Inhibition of NOX4 using Ad-NOX4i reduced Nox4 gene and protein expression
as well as H2O2 formation in EPCs. Inhibition of NOX4-derived H2O2 decreased
both proliferation and migration of EPCs. Interestingly, pro-inflammatory cytokine tumor
necrosis factor alpha (TNFα) decreased NOX4 expression and reduced survival of EPCs.
However, the survival of EPCs was further diminished by TNF-α in NOX4-knockdown
cells, suggesting that NOX4 has a protective role in EPCs.
Conclusion: These findings suggest that NOX4-type NADPH oxidase is important for
proliferation and migration functions of EPCs and protects against pro-inflammatory
cytokine induced EPC death. These properties of NOX4 may facilitate the efficient
function of EPCs which is vital for successful neovascularization.
Keywords: NOX4, H2O2, endothelial progenitor cells, ROS, TNFα
INTRODUCTION
Neovascularization is critical for normal development and in wound repair (Bauer et al., 2005; Fish
and Wythe, 2015). It is also seen as a potential option to rescue tissue from critical damage after
acute ischemia such as myocardial infarction (Isner and Asahara, 1999). Endothelial progenitor
cells (EPCs) are a type of cell able to differentiate into mature endothelial cells and are involved
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in postnatal neovascularization (Takahashi et al., 1999; Asahara
et al., 1999a,b; Aicher et al., 2005; Real et al., 2008). Evidence
continues to accumulate regarding the importance of EPCs
for restoring endothelial function in injured blood vessels and
neovascularization in ischemic tissues (Asahara et al., 1999a;
Assmus et al., 2002; Iba et al., 2002; Griese et al., 2003; Krankel
et al., 2012; Galasso et al., 2013; Lee et al., 2016).
Although currently there is no defining characteristic of
EPCs, these cells are primarily identified by expression of
haematopoietic stem cell surface antigens CD133, CD34, and
Vascular endothelial growth factor receptor 2 (VEGFR2) (Yin
et al., 1997; Peichev et al., 2000; Urbich and Dimmeler,
2004; Friedrich et al., 2006; Zengin et al., 2006; Chang et al.,
2007; Chen et al., 2007; Ranjan et al., 2009). Additionally,
EPCs take up acetylated low-density lipoprotein conjugated
1,1′-dioctadecyl- 3,3,3′,3′-tetramethylindocarbocyanine (Di-Ac-
LDL) and bind to ulex europaeus agglutinin-1 (UEA-1)
lectin. EPCs are classified as either early endothelial colony
forming cells (ECFC)or late outgrowth endothelial cells (OEC
or EOC) based on in vitro growth and survival (Asahara
et al., 2011). Peak growth is observed in early haematopoietic
EPCs, characteristically spindle shaped, at 2–3 weeks with
death occurring by 4 weeks. Late EPCs, on the other
hand, are cobblestone-like in morphology within 2–3 weeks,
demonstrate exponential growth between 4 and 8 weeks and
can survive up to 12 weeks (Marui et al., 1993; Asahara
et al., 1997; Hur et al., 2004). Furthermore, early EPCs do not
proliferate in vitro (Rehman et al., 2003) whereas, late EPCs
are highly proliferative, differentiate into mature endothelial
cells and are directly incorporated into blood vessels during
neovascularization (Hur et al., 2004; Ranjan et al., 2009; Cheng
et al., 2013).
Reactive oxygen species (ROS) including superoxide and
hydrogen peroxide (H2O2) act as double-edged swords in
pathophysiological conditions. ROS can be either protective
or destructive, depending upon the particular species (e.g.,
superoxide vs. H2O2), their location, and the amounts generated.
NADPH oxidases (NOX) are the major source of ROS and
are involved in modulation of stem or progenitor cell function
under various conditions (Imanishi et al., 2008; Schröder et al.,
2009; Ushio-Fukai and Urao, 2009; Turgeon et al., 2012; Peng
et al., 2015). The NOX family consists of 7 isoforms NOX1-5
(NOX5 is only expressed in humans) and dual oxidases (DUOX)
1 and 2 (Bedard and Krause, 2007; Brandes and Ushio-Fukai,
2011). Endothelial cells and EPCs predominantly express NOX2,
NOX4, and NOX1 isoforms of NADPH oxidase (Piccoli et al.,
2007). Each isoform differs in terms of expression, subcellular
localization, type of ROS produced and their activation (Chan
et al., 2009; Drummond et al., 2011). For instance, NOX2
isoform requires growth factors (vascular endothelial growth
factor; VEGF, and hepatocyte growth factor; HGF) or cytokines
(tumor necrosis factor alpha; TNFα and angiotensin-II; Ang
II), recruiting cytosolic subunits for full activation to produce
superoxide (Jiang et al., 2004; Cave et al., 2006; Bedard and
Krause, 2007; Frey et al., 2009; Brandes and Ushio-Fukai, 2011).
There is increasing evidence to suggest that NOX2-mediated
ROS signaling can modulate EPC function. For instance it has
been shown that NOX2-derived ROS signaling promotes the
mobilization and angiogenic capacities of bone marrow derived-
early EPCs, that can contribute to revascularization of ischemic
tissue (Urao et al., 2008) and re-endothelialization of injured
arteries (Urao et al., 2008; Schröder et al., 2009, 2011). On
the other hand, sustained overproduction of NOX2-derived
superoxide (i.e., oxidative stress) causes EPC dysfunction and
impairment of neovascularization under various pathological
conditions including heart failure, diabetes and hypertension
(Ebrahimian et al., 2006; Yao et al., 2007; Hamed et al., 2009).
Mechanistically, NOX2 derived superoxide reduces nitric oxide
(NO) bioavailability and inhibits telomerase activity, leading to
EPC senescence and dysfunction (Sorrentino et al., 2007; Hamed
et al., 2011).
In contrast to other NOX isoforms, NOX4 does not require
activation as it is constitutively active and primarily produces
H2O2 (i.e., reductive stress) instead of superoxide in endothelial
cells (Brandes et al., 2011; Takac et al., 2011; Schroder et al., 2012;
Peshavariya et al., 2014b). Recently, we and others have shown
that increased expression of NOX4 in endothelial cells protects
the cells from death and increases neovascularization in vitro and
in vivo (Schroder et al., 2012; Yan et al., 2014; Peshavariya et al.,
2014b). However, the role of NOX4 in EPC function is poorly
understood and the current study was undertaken to examine
whether or not NOX4 plays similar role in human EPCs.
MATERIALS AND METHODS
Isolation and Expansion of Cells
Human endothelial progenitor cells were isolated from human
mammary arteries/saphenous vein as described earlier (Ranjan
et al., 2009). Briefly, 2–4 cm long pieces of human mammary
artery/saphenous vein were collected as de-identified surgical
waste following written informed consent from 50 to 70
years old individuals undergoing cardiac surgery. Mammary
artery/saphenous vein samples were collected in M199 medium
containing antibiotics (penicillin 25 unit/ml, streptomycin 25
µg/ml, Ciprofloxacin 30 µg/ml, GIBCO-BRL, Burlington, ON),
then washed with PBS. Collection of such material was
approved by the NCCS research ethics committee (Ethics No.
NCCS06/198) National Center for Cell Science, Pune, India.
EPCs were detached from the luminal wall of arteries using
collagenase (1 mg/ml, Sigma, St. Louis, MO) for 15 min at 37◦C.
Sterile PBS were used to flush out the detached EPCs from the
lumen, and collected in 15 ml Falcon tubes. EPCs were washed
twice with 10 ml of PBS and then cell seeded in 10% human AB
sera and antibiotics (5 unit/ml penicillin, 5µg/ml streptomycin, 6
µg/ml Ciprofloxacin, GIBCO-BRL, Burlington, ON) containing
endothelial growth medium mix or EGMM, which was made by
mixing 50% M199 medium (GIBCO-BRL, Burlington, ON) with
EBM-2medium (Lonza,Walkersville, MD). Isolated EPCs adhere
to culture plates within 6–8 h, after which, all non-adherent
cells were removed. Adherent EPCs were expanded following
procedures described earlier (Ranjan et al., 2009) and used for
the present study.
Flow Cytometry Staining
EPCs were harvested, washed in Ca++ andMg++ free PBS before
blocking for non-specific antigens using 4% normal donkey
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serum for 20 min. CD133 one step staining was carried out using
phycoerythrin(PE)-tagged mouse anti-human CD133 antibody
(1:50; Miltenyi Biotec, Germany) and incubation at 4◦C for 45
min. Later, EPCs were washed with 5 ml PBS for three times.
Cells were then re-suspended in 300 ml of PBS. Each sample was
assessed for at least 10,000 events on a FACS Canto II system
(BD, Franklin Lakes, NJ) and then analyzed using the FACS Diva
software as described earlier (Ranjan et al., 2009).
Cell Culture
EPCs were cultured on 1% fibronectin coated dishes in EGM-2
Bullet Kit with 15% fetal bovine serum (FBS) known as EGM-
2 growth medium (Lonza, VIC, Australia). EPCs were cultured
under standard cell culture conditions using a 5% CO2 incubator
at 37◦C. Tumor necrosis factor (TNF-α) is well known to induce
Nox isoforms and cell death. In some conditions, cells were
treated with human TNF-α (20 ng/ml; Sigma, St. Louis, MO) for
6 or 48 h prior to cell harvest.
Adenovirus Infection
We silenced the expression of NOX4 gene using adenoviral
vectors carrying small interfering RNA targeting nucleotides
418–436 from the start codon of human NOX4 (Ad-NOX4i).
Briefly, 5 × 104 EPCs were cultured in a 10 cm2 plate 1
day before infecting them with Quiet-U6 vector (Welgen)
expressing the sequence against human NOX4 (nucleotides 418–
436 from the start codon). The construct was ligated into
a linearized adenoviral genome for subsequent generation of
adenoviral vector (Ad-NOX4i) (Chen et al., 2008). Adenovirus
containing green fluorescent protein gene (Adv-GFP) was used
as a control and optimized multiplicity of infection as shown in
Supplementary Figure S1. EPCs were infected with 1,000 MOI
of Ad-GFP or Ad-NOX4 RNAi for 24 h in Opti-MEM medium
(Life Technologies, Victoria, Australia), then allowed to recover
for another 24 h using EGM-2 growth medium. All experiments
were performed 48 h after infection.
Dil-Ac-LDL Uptake Assay
EPCs (103 cells/well) were seeded on 1% fibronectin coated
24-well plates in EGM-2 Bullet Kit with 5% FBS (EGM-2
growth media, Lonza, Victoria, Australia) and allowed to
attach following overnight incubation. For LDL uptake assay,
cultured medium was replaced with 10 µg/ml of acetylated low
density lipoprotein (Ac-LDL), labeled with 1,1′-dioctadecyl–
3,3,3′,3′-tetramethyl-indocarbocyanine perchlorate (DiI-Ac-
LDL, Biomedical Technologies), then cells were incubated for
additional 4 h. After the end of the incubation period, the
solution was aspirated and fresh growth medium was added
before capturing the images using fluorescence microscopy
(Zeiss AxioImager.2 microscope).
Immunostaining
Cells were fixed in 4% fresh paraformaldehyde, permeabilized
with chilled 50% methanol, blocked with 4% normal donkey
serum and then incubated with specific antisera. Primary
antibodies; mouse anti- PECAM-1 antibody (Chemicon,
Temecula, CA, 1:100), mouse anti-VE-cadherin (Chemicon,
Temecula, CA, 1:100), rabbit anti-eNOS mouse antibody
(Chemicon, Temecula, CA, 1:100) and UEA1 (Ulex europeous
agglutinin; Sigma, St. Louis, MO; 1:100), were incubated
overnight at 4◦C, washed with PBS and then incubated with
the secondary antibodies; Alexa-Fluor 488, Alexa-Fluor 546
(Molecular Probes, Carlsbad, CA, 1:200) at 37◦C for 1 h. We
used 4′, 6-diamidino-2-phenylindole (DAPI) or propidium
iodide to visualize nuclei. Slides were washed extensively with
generous volumes of PBS and mounted in Vectashield mounting
medium (Vector Laboratories, Burlingame, CA). Confocal
images for CD31 and CD144 were obtained using a Zeiss LSM
510 laser scanning microscope. All other images obtained
using Zeiss AxioImager-2 microscope fluorescence microscopy.
Results presented are representative fields confirmed from at
least three different biological samples.
Gene Expression Analysis
Cells (105 cells/well) were seeded on 6-well plates. Serum
deprived cells were treated with tumor necrosis factor; TNFα (20
ng/ml) for 6 or 48 h. Total RNA from treated cells was extracted
with the TRI reagent according to manufacturer’s instructions
(Ambion, Austin, TX, USA) and reverse-transcribed to cDNA
using TaqMan high performance reverse transcription reagents
(Applied Biosystems, Life Technologies, Victoria, Australia) at
25◦C for 10 min, 37◦C for 2 h followed by 85◦C for 5 s in
a Thermal cycler (BioRad-DNA Engine, Bio-Rad, New South
Wales, Australia). Real-time PCR reactions were performed in
a 7,300 real-time quantitative PCR system (Applied Biosystems,
Life Technologies) using TaqMan Universal PCRmaster mix and
pre-designed (off the shelf) gene specific probes and primer sets
for NOX2 (Hs00166163_m1) and NOX4 (Hs01558199_m1) The
cycle threshold (CT) values from all real-time PCR experiments
were analyzed using 11CT method. Data were normalized to
glyceraldehyde 3-phosphate dehydrogenase (GAPDH; human
4326317E) and expressed as fold changes over that in the control
treatment group.
Amplex® Red Assay
Extracellular hydrogen peroxide (H2O2) levels were detected
using Amplex R© Red assay kit (Molecular Probes, Life
Technologies, Victoria, Australia) according to manufacturer’s
instructions. EPCs (104 cells/well) were seeded on 1% fibronectin
coated 24-well plates. Serum-deprived cells were trypsinized and
suspended in Krebs-HEPES buffer (HBSS, in mM: NaCl 98.0,
KCl 4.7, NaHCO3 25.0, MgSO4 1.2, 137 KH2PO4 1.2, CaCl2
2.5, d-glucose 11.1 and Hepes-Na 20.0) containing Amplex R©
Red reagent (10 µM) and horseradish peroxidase (0.1 U/ml).
Fluorescence was then measured with excitation and emission at
550 nm and 590 nm respectively, using a polarstar microplate
reader (BMG Labtech, Germany) at 37◦C. Fluorescence values
were normalized to cell numbers determined by Alamar R© Blue
cell viability assays as according to manufacturer’s instructions
(Life Technologies, Victoria, Australia).
Proliferation Assay
EPCs (5 × 103 cells/well) were seeded on 24-well plates for 24
h before serum starvation. Serum starved-cells were induced to
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proliferate by adding EGM-2 growth mediumwith 1% FBS. After
48 h, cells were trypsinized and numbers were analyzed by using
trypan blue (Life Technologies, Victoria, Australia) and counted
using a haemocytometer.
Transwell Migration Assay
The transwell migration assay was performed using 24-
well transwell permeable inserts containing polycarbonate
membranes (6.5 mm diameter, 8 µm pore size, and 0.3 cm3
bottom area, CLS3422; Sigma-Aldrich). Inserts were incubated
with 0.1% gelatin and dried. Then, 600µl of the chemo attractant
(EGM-2 growth medium with 1% FBS) was dispensed into
each well of the 24-well transwell plates and incubated at 37◦C
for 1 h. The transwell inserts were placed in the bottom of
wells containing pre-warmed chemo attractant. EPC cells were
trypsinized and resuspended in EGM-2 growth medium with
1% FBS. 1 × 104 cells (600 µl from the cell suspension) were
added to each well. The transwell plates were then incubated at
37◦C. The number of migrated cells was counted after 16 h. The
medium in the inserts was next removed, and the membranes
were washed twice in PBS. Transwell membranes were then
fixed in cold methanol for 1 min, air dried and washed three
times before staining for nuclei using DAPI for 1 min. Transwell
membranes were then washed at least three times with generous
amounts of PBS to remove excess stain. The non-migrated cells
on the top side of the membranes were gently wiped off using wet
cotton swabs. The membranes were left to air dry and carefully
peeled off from the inserts and placed on microscopic slides,
with the migrated cells facing up down, then mounted in DEPEX
mounting medium. Quantification was carried out by imaging 10
random X10 high-power fields per membrane using an Olympus
inverted light/fluorescent microscope (Model No. IX81) and the
number of migrated cells was counted using Image J software.
Western Blot Analysis
Cells (2.5 × 105 cells/well) were cultured in 6-well plates,
and protein was extracted as previously described. Equal
amounts of protein were then separated by electrophoresis
using gradient SDS-PAGE gel, and transferred to nitrocellulose
membranes (Amersham). After blocking with 5% non-fat milk
in a buffer containing Tris–HCl (20 mM, pH 7.5), NaCl
(100 mM) and Tween 20 (0.1%), respective membranes were
incubated at 4◦C overnight with primary rabbit monoclonal anti-
NOX4 (1:1,000, Abcam, Australia) and mouse monoclonal anti-
GAPDH (1:1,000, Merck Millipore) antibodies. Proteins were
detected using an enhanced chemiluminescence detection kit
(GE Healthcare, New South Wales, Australia) with horseradish
peroxidase conjugated to appropriate secondary antibodies (Bio-
Rad, New South Wales, Australia). The image was captured and
processed using CanoScan 8800F/PhotoStudio 5.5 software.
Data and Statistics
Data are expressed as mean± standard error of the mean (SEM).
The mean data were analyzed with Student’s t-test or One-way
analysis of the variance (ANOVA) followed by post-hoc Tukey or
Dunnett analysis. A value of P< 0.05 was regarded as statistically
significant.
RESULTS
Characterization and Expansion of EPCs
EPCs have been successfully isolated and expanded in culture
from different sources (Takahashi et al., 1999; Kalka et al., 2000;
Yamaguchi et al., 2003; Ingram et al., 2004; Li et al., 2006).
Here, EPCs were isolated from the luminal wall of human
mammary artery/saphenous vein and expanded in vitro under
low cell density culture conditions (103 cells/cm2). EPCs formed
colonies within 14 days (Figure 1A) and immunophenotyping
showed high expression of hematopoietic marker CD133 at
low density as compared to isotype controls (Figures 1B,C).
Adherent EPCs stained positive for Dil-Ac-LDL (Figure 1D) and
UEA-1 lectin (Figure 1E). Moreover, these cells stained positive
for expression of the endothelial marker protein endothelial
nitric oxide synthase (eNOS; Figure 1F).
Early and late EPCs can be distinguished by their proliferative
property and life span in culture (Marui et al., 1993; Asahara
et al., 1997; Hur et al., 2004). We examined proliferative potential
of our expanded progenitor cells from three different patients.
Cells were plated on day 0, and then serially passaged to maintain
cells under proliferative phase for 60 days. Remarkably, colonies
derived from EPCs started to appear from 20 days (Figure 2),
suggesting that these cells are late EPCs. Every 10 days, the
number of EPCs expanded until the induction reached around
3,500-fold within 60 days. This finding suggests that late EPCs
can be expanded for a long time in vitro.
Differentiation of EPCs to Endothelial Cells
EPCs can be readily differentiated to endothelial cells. We
examined the differentiation capacity of late EPCs which were
plated at a high cell density (8 × 104 cells/cm2) onto tissue
FIGURE 1 | Characterization of human EPCs. (A) Bright field image of
EPCs at low density (103 cells/cm2 ) showing that they form colonies in vitro
within 2 weeks. Compared with Isotype control (B), FACS analysis of EPCs (C)
at low density shows these cells express CD133. EPCs have the ability to
uptake (D) Dil-Ac-LDL (10 µg/mL; Biomedical Technologies), and stain
positive for both (E) UEA-1 (1:100; Vector Laboratories) and (F) eNOS (1:100;
cell signaling). Propidium iodide (red; E,F) was used for nuclear staining.
Images were taken by fluorescent microscopy (Scale bar = 10 µm).
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FIGURE 2 | Growth kinetics of the human isolated EPCs. The figure
shows a growth curve of isolated EPCs from three different patients (N = 3).
Isolated EPCs show an initial lag phase of growth (20–30 days) before entering
an exponential growth phase. Around 3,500-fold expansion was observed
within 2 months of isolation with an average doubling time of 5.0 days. Values
(means ± SEM; n = 3) are expressed as cell counts **p < 0.05 from number
of cells at day 0. Data were analyzed with one-way ANOVA followed by
post-hoc Dunnett analysis.
culture treated chambers. Within 8 days late EPC had matured
into endothelial cells which showed cobblestone morphology, as
well as expressing endothelial markers PECAM-1 (Figure 3A)
and VE-cadherin (Figure 3B).
Nox4 Is Required for H2O2 Generation in
Late EPCs
To demonstrate the importance of NOX4 function in EPCs,
adenovirus expressing RNA interference targeting human NOX4
(Ad-NOX4i) was used to suppress NOX4 gene expression.
Inhibition of NOX4 using Ad-NOX4i (1,000 MOI) markedly
reduced both NOX4mRNA (Figure 4A) and protein (Figure 4B)
expression compared with the control group (Ad-GFP).
Moreover, Ad-NOX4i suppressed H2O2 production in late EPCs
(Figure 4C), confirming that NOX4 promoted H2O2 generation
in late EPCs.
NOX4 Is Involved in EPC Proliferation and
Migration
NOX4 has been also reported to mediate vascular cells
proliferation and migration (Petry et al., 2006; Sturrock et al.,
2006; Datla et al., 2007; Ismail et al., 2009; Peshavariya et al.,
2009, 2014a,b). As shown in Figure 5A, EPC proliferation was
clearly reduced after knocking down NOX4 using Ad-NOX4i
when compared with control (Ad-GFP). We also examined
the contribution of Nox4 on EPC migration using transwell
migration assay. For this purpose, 1 × 104 of Ad-GFP and
Ad-NOX4i EPCs were seeded on the upper chamber of the
transwell inserts and stimulated with EGM-2 growth medium +
1% FBS to pass to the lower chamber. The number of migratory
cells was significantly decreased after inhibition of NOX4 gene
when compared with the control (Ad-GFP) (Figures 5B,C). Thus
NOX4 is required for proliferation and migration of EPCs.
FIGURE 3 | In vitro differentiation of EPCs to endothelial cells and
characterization. EPCs at high density (86 × 104 cells/cm2 ) differentiate into
mature endothelial cells with cobblestone morphology as seen in (A,B).
Characterization of in vitro differentiated endothelial cells demonstrates that
these cells are immunopositive for endothelial cell specific markers: (A)
PECAM-1 (Scale bar 20µM) and (B) VE-cadherin (Scale bar 50µM). DAPI
(blue; A,B) was used for nuclear staining (Scale Bar = 50 µm).
TNFα Has a Differential Effect on
Expression of NOX2 and NOX4 Isoforms in
EPCs
Pro-inflammatory cytokines such as TNFα, induce to oxidative
stress via escalating ROS production (Kim et al., 2010)
particularly from NADPH oxidase (Chandel et al., 2001). TNFα
up-regulated the expression of NOX2 over 6 h, which was
further induced inNOX4- deficient cells (Figure 6A). In contrast,
NOX4 expression decreased after TNFα treatment. There was no
significant difference in NOX4 expression before and after TNFα
treatment in NOX4 deficient cells (Figure 6B), indicating that
TNFα selectively modulates NOX isoforms in EPCs.
NOX4 Protects EPCs from Cell Death
Ad-GFP carrying EPCs treated with TNFα (20 ng/ml) for 48
h significantly increased cell death. Suppression of NOX4 gene
using NOX4 RNAi in the absence of TNFα also increased cell
death. Interestingly, the effect of TNFα on cell death was further
enhanced in NOX4 deficient cells (Figure 7), indicating that
NOX4 helps to protect EPCs.
DISCUSSION
We isolated highly proliferative CD133+ late EPCs from blood
vessels and differentiated them into mature endothelial cells.
We showed that NOX4 type NADPH oxidase is constitutively
active and generates H2O2 in EPCs, whilst suppression of
NOX4 reduced both their proliferation and migration. The pro-
inflammatory cytokine TNFα reduced NOX4 expression and
induced EPCs death. These finding suggest that endogenous
NOX4 NADPH oxidase is important for EPC proliferation and
migration and protects the cells under inflammatory conditions.
EPCs play a vital role in vascular homeostasis through re-
endothelialization and neovascularization (Asahara et al., 1999a;
Assmus et al., 2002; Iba et al., 2002; Griese et al., 2003; Urao
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FIGURE 4 | Inhibition of NOX4 reduced NOX4 expression and H2O2 generation in late EPCs. (A) Inhibition of NOX4 gene using NOX4 RNAi markedly
reduced NOX4 mRNA expression in EPCs. (B) Lack of NOX4 decreased NOX4 protein level when compared to control in EPCs using a specific NOX4 antibody as
shown in a representative Western Blot. (C) H2O2 generation was reduced after NOX4 inhibition using Amplex red. Values (means ± SEM; n = 3–5), *P < 0.05 from
Ad-GFP control following a Student’s paired t-test.
FIGURE 5 | Inhibition of NOX4 reduced proliferation and migration of
late EPCs. (A) EGM-2 growth medium was used to induce endothelial cell
proliferation in Ad-GFP and ad-NOX4i. Cell proliferation was measured using
trypan blue cell counting. Deficiency of NOX4 gene significantly reduced EPC
proliferation compared with control (Ad-GFP). (B) Representative images
showing a reduction in the number of migrated cells, stained with nuclear
counter-stain DAPI after inhibition of NOX4 gene, compared with Ad-GFP
control in the transwell migration assay (original magnification 40×) Scale bar
= 10 µm. (C) Graph represents the quantitative data of Ad-GFP vs. Ad-NOX4i
cell migration. Values (means ± SEM; n = 3–4) are expressed as cell counts,
*P < 0.05 from Ad-GFP control following a Student’s paired t-test.
et al., 2008; Schröder et al., 2009, 2011). Although, EPCs have
been widely investigated for more than a decade, it is unclear how
this cell population should be defined since no unique marker
has been identified. During embryonic development, progenitors
cells such as haemangioblasts give rise endothelial cells. These
precursor cells are characterized by CD133 expression (Peichev
et al., 2000), are highly proliferative and mediate an important
role of ischemic tissues regeneration as well as repair of damaged
blood vessels repair (Kocher et al., 2001). We and others have
shown that CD133+ EPC populations can be isolated and
expanded from various tissues such as blood vessels (Ranjan et al.,
2009), heart (Beltrami et al., 2003), peripheral blood (Asahara
et al., 1997), umbilical cord blood (Murohara et al., 2000) and
bone marrow (Shi et al., 1998). Consistent with our previous
study (Ranjan et al., 2009), blood vessel- derived EPCs retained
the haematopoietic stemness marker CD133 in low density
culture conditions and formed large cell colonies, take up Di-Ac-
LDL, are positive for UEA-1 conjugated FITC binding and eNOS
expression, and these features define EPC lineages. In addition
to cell surface marker characteristics, EPCs are also characterized
by certain biological properties such as proliferation and life span
in culture conditions. It has been shown that haematopoietic
early EPCs exhibit peak growth within 2 weeks and die by 4
weeks, whereas, late EPCs have a cobblestone-like morphology,
they exhibit exponential growth at 4–8 weeks and can survive
for up to 12 weeks (Marui et al., 1993; Asahara et al., 1997; Hur
et al., 2004). Similarly, we observed that blood vessel- derived
EPCs appeared cobblestone-like in morphology (Figure 1A) and
proliferated exponentially after 3 weeks (Figure 2). Furthermore,
EPCs spontaneously differentiated into endothelial cells under
high density culture conditions and stained positive for CD31
and VE-cadherin (Figures 3A,B). These findings suggest that
the human vascular wall retains CD133+ late EPCs that can be
expanded in vitro.
NADPH oxidase-derived ROS signaling has been implicated
in stem or progenitor cell function. More specifically ischemia
mediated NOX2- derived ROS play a critical role in early EPC
function such as mobilization, homing, and angiogenic capacity,
thereby promoting revascularization of ischemic tissue (Urao
et al., 2008) and re-endothelialization of injured blood vessels
(Schröder et al., 2009). A later study also indicates that the NOX2
expression is higher than other NOX isoforms in human blood
derived early EPCs and can be further stimulated in the presence
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FIGURE 6 | TNFα has a differential effect on NOX isoform expression in
EPCs. (A) After TNFα treatment (20 ng/ml; 6 h), NOX2 mRNA levels increased
in Ad-GFP cells and increased in NOX4 deficient cells. (B) Conversely, NOX4
mRNA expression was reduced in Ad-GFP infected cells and this was
abolished in NOX4 deficient cells. Values (means ± SEM; n = 4) are expressed
as a fold change compared with control (Ad-GFP), *P < 0.05 from Ad-GFP
control. Data were analyzed with one-way ANOVA followed by post-hoc Tukey
analysis. NS: Not significant.
FIGURE 7 | NOX4 protects EPCs from TNFα-induced cell death. Treating
EPCs with TNFα (20 ng/ml; 48 h) induced cell death, which was further
enhanced with NOX4 gene inhibited. Values (means ± SEM; n = 3–5) are
represented as a percentage of control, *P < 0.05 from Ad-GFP control, #P
< 0.05 from Ad-NOX4i. Data were analyzed with one-way ANOVA followed by
post-hoc Tukey analysis.
of erythropoietin or under hypoxic conditions. In the present
study, we demonstrated that NOX4 is an important source of
H2O2 in CD133+ late EPCs. Moreover, inhibition of NOX4
reduces proliferation and migration of EPCs which are vital for
angiogenesis (Figure 5). As with EPCs, we and others have shown
that NOX4- deficient endothelial cells exhibit reduced in vitro
proliferation and migration as well as in vivo angiogenesis (Petry
et al., 2006; Datla et al., 2007; Peshavariya et al., 2009, 2014a;
Craige et al., 2011). This functional similarity may be due to
hierarchal preservation of NOX4 signaling in late EPCs as they
mature.
The precise mechanisms by which NOX4 modulates
functional activities of EPCs remain to be determined. However,
previous studies have demonstrated that NOX4-derived H2O2
targets several proteins such as protein-tyrosine phosphatase
1 B (PTP1B) (Chen et al., 2008) and hypoxia-inducible factor
1-alpha (HIF1-α) (Zhang et al., 2010). Indeed, we and others
have shown that NOX4 inhibits PTP1B and enhanced VEGF
mediated cell signaling pathways in endothelial cells (Datla et al.,
2007; Chen et al., 2008). A separate study has also revealed that
NOX4 stabilizes HIF1-α and enhances VEGF expression (Meng
et al., 2012). Elevation of growth factor expression and activity
or both may enhance the function of EPCs in an autocrine or
paracrine fashion and such a downstream target of NOX4 in
EPCs needs to be explored in the future.
In contrast to NOX4 isoform-derived reductive stress, a
sustained increase in oxidative stress due to aging and chronic
pathological conditions such as diabetes and inflammation may
impact on EPC numbers and functions (Ebrahimian et al., 2006;
Hamed et al., 2009). Indeed, many lines of evidence indicate
that NOX2-derived oxidative stress reduces circulating EPCs in
diabetic patients as well as hampering the neovascularization
efficiency of EPCs in an experimental model of hind limb
ischaemia in agedmice (Turgeon et al., 2012). Moreover, separate
studies show that the pro-inflammatory cytokine TNFα also
activates NOX2 and reduces the viability of endothelial cells (Frey
et al., 2002; Li et al., 2005; Schroder et al., 2012) and EPCs (Du
et al., 2014). Consistent with these studies, we found chronic
exposure to TNFα induces NOX2 expression and decreases
survival of EPCs. Interestingly, TNFα decreased the expression
of NOX4 and further reduced EPC viability in NOX4 deficient
cells suggesting that NOX4 provides protective signaling which
is important for EPC survival. Although precisely how TNFα
reciprocates NOX isoform expression in EPCs remains to be
identified. In addition, Nox isoforms expression also altered as
diseases progress which may lead to dysfunctionality of EPC.
Indeed Zhang et al. shown that EPC obtained from coronary
artery diseases patients have reduced migration and angiogenic
activity compared to healthy subjects due to activation of
p47Phox subunit (required for Nox2 and Nox1 isoforms; Zhang
et al., 2016). In the present study, we have isolated EPC from
blood vessels derived from cardiac surgery patients and did not
compared with healthy subjects. It is a limitation of present work
and such a comparison study required to identify the precise role
of Nox4 in EPC.
In conclusion, we found that NOX4 type NADPH oxidase is
constitutively active and generates H2O2 in CD133+ late EPCs.
In addition, NOX4 is important for proliferation, migration
and survival of EPCs which are vital for neovascularization.
Recently we have shown that a prostacyclin analog can
increase NOX4 expression in endothelial cells and EPCs and
promotes angiogenesis in vitro and in vivo (Peshavariya
et al., 2014b). Collectively, these findings suggest that
targeting NOX4 in EPCs may be a therapeutically feasible
approach to enhance the repair of damaged blood vessels and
neovascularization.
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